Anti‐A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital‐based cohort study

BACKGROUND: Intravenous immunoglobulins (IVIG) are derived from large human plasma pools. IVIG‐associated hemolytic anemia (HA) is a known class effect, likely attributed to dose‐dependent passive transfer of anti‐A/B isoagglutinins. Two isoagglutinin reduction steps were implemented in the manufact...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallenhorst, Christopher, Patel, Ami, Shebl, Amgad, Hubsch, Alphonse, Simon, Toby L., Martinez, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Transfusion Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496198/
https://www.ncbi.nlm.nih.gov/pubmed/32488887
http://dx.doi.org/10.1111/trf.15859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496198/
https://www.ncbi.nlm.nih.gov/pubmed/32488887
http://dx.doi.org/10.1111/trf.15859

Ejemplares similares